Total Payments
$21,492
2024 Payments
$1,033
Companies
26
Transactions
158
Medicare Patients
3,991
Medicare Billing
$601,139
Payment Breakdown by Category
Other$7,900 (36.8%)
Food & Beverage$6,673 (31.0%)
Consulting$5,563 (25.9%)
Travel$1,278 (5.9%)
Education$78.61 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $7,900 | 3 | 36.8% |
| Food and Beverage | $6,673 | 144 | 31.0% |
| Consulting Fee | $5,563 | 2 | 25.9% |
| Travel and Lodging | $1,278 | 7 | 5.9% |
| Education | $78.61 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $8,192 | 24 | $0 (2024) |
| CVRx, Inc. | $3,404 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,043 | 19 | $0 (2024) |
| Akcea Therapeutics, Inc. | $2,191 | 4 | $0 (2019) |
| Abbott Laboratories | $1,354 | 34 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,085 | 8 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $343.51 | 5 | $0 (2023) |
| Novo Nordisk Inc | $285.33 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $207.16 | 9 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $160.29 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,033 | 31 | ABIOMED ($291.38) |
| 2023 | $6,596 | 37 | CVRx, Inc. ($3,200) |
| 2022 | $576.14 | 10 | ABIOMED ($263.00) |
| 2021 | $594.46 | 11 | ABIOMED ($134.09) |
| 2020 | $368.26 | 5 | Abbott Laboratories ($199.89) |
| 2019 | $4,624 | 13 | ABIOMED ($2,340) |
| 2018 | $6,326 | 32 | ABIOMED ($4,681) |
| 2017 | $1,373 | 19 | Abbott Laboratories ($375.70) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $50.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Cardio-renal | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Obesity | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Not Applicable | ||||||
| 08/07/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $122.23 | General |
| Category: Heart Failure | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $86.49 | General |
| Category: Heart Failure | ||||||
| 07/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $113.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Obesity | ||||||
| 06/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Heart Failure | ||||||
| 05/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 958 | 1,506 | $465,504 | $149,075 |
| 2022 | 8 | 968 | 1,545 | $425,047 | $146,451 |
| 2021 | 10 | 1,043 | 1,702 | $483,059 | $166,033 |
| 2020 | 12 | 1,022 | 1,730 | $459,725 | $139,581 |
Total Patients
3,991
Total Services
6,483
Medicare Billing
$601,139
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 145 | 553 | $165,900 | $55,821 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 278 | 354 | $123,948 | $41,335 | 33.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 90 | 94 | $50,572 | $13,936 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 65 | $25,610 | $8,784 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 110 | 118 | $24,964 | $8,153 | 32.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 37 | $22,792 | $6,834 | 30.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 38 | 38 | $18,833 | $5,644 | 30.0% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 24 | 24 | $12,144 | $2,785 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 27 | $7,506 | $2,521 | 33.6% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2023 | 27 | 27 | $5,967 | $1,481 | 24.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 119 | 127 | $4,064 | $829.45 | 20.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 14 | 18 | $1,296 | $475.90 | 36.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 11 | 12 | $864.00 | $327.36 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $1,044 | $149.52 | 14.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 129 | 499 | $145,553 | $43,429 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 233 | 315 | $91,088 | $37,267 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 254 | 317 | $56,347 | $22,596 | 40.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 77 | 78 | $43,414 | $13,212 | 30.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 47 | $28,952 | $8,850 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 44 | $14,794 | $6,304 | 42.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 43 | 43 | $18,659 | $6,099 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 39 | $8,918 | $3,407 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,736 | $2,958 | 38.2% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2022 | 26 | 26 | $5,746 | $1,541 | 26.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 100 | 120 | $3,840 | $787.76 | 20.5% |
About Dr. Robert Gordon, MD
Dr. Robert Gordon, MD is a Internal Medicine healthcare provider based in Evanston, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417974973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gordon, MD has received a total of $21,492 in payments from pharmaceutical and medical device companies, with $1,033 received in 2024. These payments were reported across 158 transactions from 26 companies. The most common payment nature is "Honoraria" ($7,900).
As a Medicare-enrolled provider, Gordon has provided services to 3,991 Medicare beneficiaries, totaling 6,483 services with total Medicare billing of $601,139. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease
- Location Evanston, IL
- Active Since 07/17/2006
- Last Updated 12/10/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417974973
Products in Payments
- Impella (Device) $8,192
- Barostim Neo System (Device) $3,404
- ENTRESTO (Drug) $2,874
- TEGSEDI (Drug) $2,191
- HeartWare HVAD (Device) $1,085
- Circulatory Support (Device) $406.74
- CardioMEMS HF System (Device) $266.67
- HeartMate 3 Left Ventricular Dev (Device) $240.68
- CARDIOMEMS (Device) $209.80
- Kerendia (Drug) $189.93
- LEQVIO (Drug) $169.04
- LifeVest (Device) $160.29
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $134.59
- FARXIGA (Drug) $121.60
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS (Device) $118.30
- LINQ II (Device) $116.99
- BRILINTA (Drug) $115.39
- ONPATTRO (Drug) $112.56
- remede System (Device) $106.87
- ACTHAR (Biological) $104.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evanston
Mark Metzl, Md, MD
Internal Medicine — Payments: $738,437
Internal Medicine $738,437
Dr. Jeffrey Geohas, M.d, M.D
Internal Medicine — Payments: $73,122
Internal Medicine $73,122
Dr. Jonathan Rosenberg, Md, MD
Internal Medicine — Payments: $61,345
Internal Medicine $61,345
Dr. Shashi Bellam, Md, MD
Internal Medicine — Payments: $41,682
Internal Medicine $41,682
Eileen Gajo, Md, MD
Internal Medicine — Payments: $34,462
Internal Medicine $34,462
Manoj Mehta, Md, MD
Internal Medicine — Payments: $32,356
Internal Medicine $32,356